EGFR and non-small cell lung carcinoma: Furthermore, we investigated the usefulness of the proposed framework in a real medical application by evaluating reproducible radiomics features to non-invasively predict epidermal growth factor receptor (EGFR) mutant status in non-small cell lung cancer (NSCLC) patients.